UBS Group’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-8,640
| Closed | -$3K | – | 7497 |
|
|
2018
Q2 | $3K | Buy |
+8,640
| New | +$3K | ﹤0.01% | 6770 |
|
|
2018
Q1 | – | Sell |
-4,371
| Closed | -$6K | – | 7415 |
|
|
2017
Q4 | $6K | Sell |
4,371
-11,082
| -72% | -$15.2K | ﹤0.01% | 6373 |
|
|
2017
Q3 | $35K | Sell |
15,453
-109,077
| -88% | -$247K | ﹤0.01% | 5168 |
|
|
2017
Q2 | $168K | Buy |
124,530
+117,910
| +1,781% | +$159K | ﹤0.01% | 3987 |
|
|
2017
Q1 | $14K | Buy |
6,620
+564
| +9% | +$1.19K | ﹤0.01% | 5511 |
|
|
2016
Q4 | $26K | Buy |
6,056
+63
| +1% | +$270 | ﹤0.01% | 5429 |
|
|
2016
Q3 | $29K | Sell |
5,993
-53
| -0.9% | -$256 | ﹤0.01% | 5111 |
|
|
2016
Q2 | $20K | Buy |
6,046
+53
| +0.9% | +$175 | ﹤0.01% | 5453 |
|
|
2016
Q1 | $21K | Buy |
+5,993
| New | +$21K | ﹤0.01% | 5362 |
|